All posts by: Michael Zand

About Michael Zand

New target antigen could make CAR-T possible for glioblastomas – FierceBiotech

Continue reading

2018-03-01 NEWS

FierceBiotech

New target antigen could make CART possible for glioblastomas
FierceBiotech
Surgery, radiation and chemotherapy just don’t cut it against glioblastoma, a type of aggressive brain tumor with a dismal five-year survival rate. Survival is highest in younger people, at 19% for those aged 20 to 44, but it drops sharply with age

Continue reading

2018-03-01 NEWS

Medical Xpress

Stemcell study points to new approach to Alzheimer’s disease
Medical Xpress
The system that shuttles them around the cell is the endosomal network. For proteins to be properly processed, eliminated or recycled, this system must function correctly. In the new study reported this week, the UW Medicine-led research team used

and more »